Advertisement
Commentary| Volume 95, ISSUE 4, P331-334, April 2017

Does using the “pregnancy checklist” delay safe initiation of contraception?

      In the 2013 and 2016 Centers for Disease Control and Prevention (CDC) Selected Practice Recommendations (SPR) for Contraceptive Use, the term “reasonably certain” appears at least 40 times and indicates that a health care provider should be reasonably certain that the woman is not already pregnant before initiating a contraceptive [
      • Curtis K.M.
      • Bauer U.
      • Barfield W.
      Natl Ctr chronic dis P. US selected practice recommendations for contraceptive use, 2013 adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.
      ,
      • Curtis K.M.
      • Jatlaoui T.C.
      • Tepper N.K.
      • et al.
      U.S. selected practice recommendations for contraceptive use, 2016.
      ]. The SPR state that “in most cases, a detailed history provides the most accurate assessment of pregnancy risk in a woman who is about to start using a contraceptive method” and that a provider can be “reasonably certain” if a woman has no signs or symptoms of pregnancy and passes the Pregnancy Checklist [
      • Curtis K.M.
      • Bauer U.
      • Barfield W.
      Natl Ctr chronic dis P. US selected practice recommendations for contraceptive use, 2013 adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.
      ,
      • Curtis K.M.
      • Jatlaoui T.C.
      • Tepper N.K.
      • et al.
      U.S. selected practice recommendations for contraceptive use, 2016.
      ]. This language mirrors that of the World Health Organization's (WHO) SPR for Contraceptive Use [
      • World Health Organization
      Selected practice recommendations for contraceptive use.
      ,
      • World Health Organization
      Selected practice recommendations for contraceptive use, 2008 update.
      ]. Written for global use, including low-resource settings, the WHO's SPR also incorporate the use of reasonable certainty in initiating contraceptive methods.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Curtis K.M.
        • Bauer U.
        • Barfield W.
        Natl Ctr chronic dis P. US selected practice recommendations for contraceptive use, 2013 adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.
        MMWR Recomm Rep. 2013; 62: 1-59
        • Curtis K.M.
        • Jatlaoui T.C.
        • Tepper N.K.
        • et al.
        U.S. selected practice recommendations for contraceptive use, 2016.
        MMWR Recomm Rep. 2016; 65: 1-66
        • World Health Organization
        Selected practice recommendations for contraceptive use.
        2nd ed. 2004
        • World Health Organization
        Selected practice recommendations for contraceptive use, 2008 update.
        2008
        • Stanback J.
        • Nutley T.
        • Gitonga J.
        • Qureshi Z.
        Menstruation requirements as a barrier to contraceptive access in Kenya.
        East Afr Med J. 1999; 76: 124-126
        • Stanback J.
        • Qureshi Z.
        • Sekadde-Kigondu C.
        • Gonzalez B.
        • Nutley T.
        Checklist for ruling out pregnancy among family-planning clients in primary care.
        Lancet. 1999; 354: 566
        • Labbok M.H.
        Breastfeeding as a women's issue: conclusions and consensus, complementary concerns, and next actions.
        Int J Gynaecol Obstet. 1994; : S55-S61
        • Stanback J.
        • Nanda K.
        • Ramirez Y.
        • Rountree W.
        • Cameron S.B.
        Validation of a job aid to rule out pregnancy among family planning clients in Nicaragua.
        Rev Panam Salud Publica. 2008; 23: 116-118
        • Tepper N.K.
        • Marchbanks P.A.
        • Curtis K.M.
        Use of a checklist to rule out pregnancy: a systematic review.
        Contraception. 2013; 87: 661-665
        • Torpey K.
        • Mwenda L.
        • Kabaso M.
        • et al.
        Excluding pregnancy among women initiating antiretroviral therapy: efficacy of a family planning job aid.
        BMC Public Health. 2010; 10
        • Stanback J.
        • Diabate F.
        • Dieng T.
        • de Morales T.D.
        • Cummings S.
        • Traore M.
        Ruling out pregnancy among family planning clients: the impact of a checklist in three countries.
        Stud Fam Plann. 2005; 36: 311-315
        • Min J.
        • Buckel C.
        • Secura G.M.
        • Peipert J.F.
        • Madden T.
        Performance of a checklist to exclude pregnancy at the time of contraceptive initiation among women with a negative urine pregnancy test.
        Contraception. 2015; 91: 80-84
        • Whiteman M.K.
        • Tepper N.K.
        • Kottke M.
        • et al.
        Using a checklist to assess pregnancy in teenagers and young women.
        Obstet Gynecol. 2014; 123: 777-784
        • Bracken M.B.
        Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies.
        Obstet Gynecol. 1990; 76: 552-557
        • Gray R.H.
        • Pardthaisong T.
        In utero exposure to steroid contraceptives and survival during infancy.
        Am J Epidemiol. 1991; 134: 804-811
        • Jaffe B.
        • Harlap S.
        • Baras M.
        • et al.
        Long-term effects of MPA on human progeny: intellectual development.
        Contraception. 1988; 37: 607-619
        • Pardthaisong T.
        • Gray R.H.
        In utero exposure to steroid contraceptives and outcome of pregnancy.
        Am J Epidemiol. 1991; 134: 795-803
        • Pardthaisong T.
        • Yenchit C.
        • Gray R.
        The long-term growth and development of children exposed to depo-Provera during pregnancy or lactation.
        Contraception. 1992; 45: 313-324
        • Westhoff C.
        • Heartwell S.
        • Edwards S.
        • et al.
        Initiation of oral contraceptives using a quick start compared with a conventional start - a randomized controlled trial.
        Obstet Gynecol. 2007; 109: 1270-1276
        • Rickert V.I.
        • Tiezzi L.
        • Lipshutz J.
        • Leon J.
        • Vaughan R.D.
        • Westhoff C.
        Depo now: preventing unintended pregnancies among adolescents and young adults.
        J Adolesc Health. 2007; 40: 22-28
        • Estes C.M.
        • Ramierez J.
        • Tiezzi L.
        • Westhoff C.
        Self pregnancy testing in an urban family planning clinic: promising results for a new approach to contraceptive follow-up.
        Contraception. 2008; 77: 40-43
        • Morroni C.
        • Grams M.
        • Tiezzi L.
        • Westhoff C.
        Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection.
        Contraception. 2004; 70: 19-23
        • Schafer J.E.
        • Osborne L.M.
        • Davis A.R.
        • Westhoff C.
        Acceptability and satisfaction using quick start with the contraceptive vaginal ring versus an oral contraceptive.
        Contraception. 2006; 73: 488-492
        • Schwarz E.B.
        • Kavanaugh M.
        • Douglas E.
        • Dubowitz T.
        • Creinin M.D.
        Interest in intrauterine contraception among seekers of emergency contraception and pregnancy testing.
        Obstet Gynecol. 2009; 113: 833-839
        • Sneed R.
        • Westhoff C.
        • Morroni C.
        • Tiezzi L.
        A prospective study of immediate initiation of depo medroxyprogesterone acetate contraceptive injection.
        Contraception. 2005; 71: 99-103
        • Turok D.K.
        • Sanders J.N.
        • Thompson I.S.
        • Royer P.A.
        • Eggebroten J.
        • Gawron L.M.
        Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
        Contraception. 2016; 93: 526-532
        • Westhoff C.
        • Kerns J.
        • Morroni C.
        • Cushman L.F.
        • Tiezzi L.
        • Murphy P.A.
        Quick start: novel oral contraceptive initiation method.
        Contraception. 2002; 66: 141-145
        • Westhoff C.
        • Morroni C.
        • Kerns J.
        • Murphy P.A.
        Bleeding patterns after immediate vs. conventional oral contraceptive initiation: a randomized, controlled trial.
        Fertil Steril. 2003; 79: 322-329
        • Westhoff C.
        • Osborne L.M.
        • Schafer J.E.
        • Morroni C.
        Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
        Obstet Gynecol. 2005; 106: 89-96
        • Ohlemeyer C.L.
        Adolescents' compliance with return visits for depot medroxyprogesterone initiation.
        J Pediatr Adolesc Gynecol. 2003; 16: 297-299
        • Dehlendorf C.
        • Levy K.
        • Kelley A.
        • Grumbach K.
        • Steinauer J.
        Women's preferences for contraceptive counseling and decision making.
        Contraception. 2013; 88: 250-256
        • Nippita S.
        • Velasco M.G.
        • Oviedo J.D.
        • Westhoff C.L.
        • Davis A.R.
        • Castano P.M.
        90-day bleeding patterns after intrauterine device insertion a prospective parallel cohort study.
        Obstet Gynecol. 2014; 123: 12S-S
        • Biggs M.A.
        • Harper C.C.
        • Brindis C.D.
        California family planning health care Providers' challenges to same-day long-acting reversible contraception provision.
        Obstet Gynecol. 2015; 126: 338-345
        • Waller D.K.
        • Gallaway M.S.
        • Taylor L.G.
        • et al.
        Use of oral contraceptives in pregnancy and major structural birth defects in offspring.
        Epidemiology. 2010; 21: 232-239
        • Turok D.K.
        • Godfrey E.M.
        • Wojdyla D.
        • Dermish A.
        • Torres L.
        • Wu S.C.
        Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
        Hum Reprod. 2013; 28: 2672-2676
        • Brahmi D.
        • Steenland M.W.
        • Renner R.-M.
        • Gaffield M.E.
        • Curtis K.M.
        Pregnancy outcomes with an IUD in situ: a systematic review.
        Contraception. 2012; 85: 131-139
        • Castano P.
        • Vander Haar E.
        • Brown K.
        • et al.
        Yes We can: Quickstart initiation of levonorgestrel-releasing intrauterine system (LNG-IUS).
        Contraception. 2014; 90: 331-332
        • Nippita S.V.
        • MG
        • Oviedo J.D.
        • Westhoff C.L.
        • Davis A.R.
        • Castano P.M.
        90-day bleeding patterns after intrauterine device insertion.
        Obstet Gynecol. 2014; 123: 1
        • Brache V.
        • Cochon L.
        • Deniaud M.
        • Croxatto H.B.
        Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.
        Contraception. 2013; 88: 611-618
        • Glasier A.
        The rationale for use of ulipristal acetate as first line in emergency contraception: biological and clinical evidence.
        Gynecol Endocrinol. 2014; 30: 688-690
        • Brache V.
        • Cochon L.
        • Duijkers I.J.
        • et al.
        A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception.
        Hum Reprod. 2015; 30: 2785-2793
        • Reeves M.F.
        • Zhao Q.
        • Secura G.M.
        • Peipert J.F.
        Risk of unintended pregnancy based on intended compared to actual contraceptive use.
        Am J Obstet Gynecol. 2016; 215: e1-e6